Omada Health, Inc. Operating Income
Omada Health, Inc. (OMDA) reported Operating Income of $3.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-07
- Omada Health, Inc. operating income (loss) for the quarter ending 2026-06-30 was $3.55M.
- Omada Health, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$4.78M.
- Omada Health, Inc. operating income (loss) for the quarter ending 2025-12-31 was $3.28M.
- Omada Health, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$2.51M.
- Omada Health, Inc. operating income (loss) for fiscal 2025 was -$11.97M.
- Omada Health, Inc. operating income (loss) for fiscal 2024 was -$43.65M.
- Omada Health, Inc. operating income (loss) for fiscal 2023 was -$66.00M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.55M 10-Q · filed 2026-08-07 | -$1.23M 10-Q · filed 2026-08-07 | $2.05M derived: sum of 3 quarters · filed 2026-08-07 | -$464.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$4.78M 10-Q · filed 2026-05-08 | -$1.50M derived: sum of 2 quarters · filed 2026-05-08 | -$4.01M derived: sum of 3 quarters · filed 2026-05-08 | -$8.36M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $768.00K derived: sum of 2 quarters · filed 2026-03-06 | -$3.58M derived: sum of 3 quarters · filed 2026-08-07 | -$11.97M 10-K · filed 2026-03-06 |
| 2025-09-30 | -$2.51M 10-Q · filed 2025-11-07 | -$6.86M derived: sum of 2 quarters · filed 2026-08-07 | -$15.25M 10-Q · filed 2025-11-07 | -$22.35M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$4.34M 10-Q · filed 2026-08-07 | -$12.74M 10-Q · filed 2026-08-07 | -$19.84M derived: sum of 3 quarters · filed 2026-08-07 | -$28.36M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$8.40M 10-Q · filed 2026-05-08 | -$15.50M derived: sum of 2 quarters · filed 2026-05-08 | -$24.02M derived: sum of 3 quarters · filed 2026-05-08 | -$34.06M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$15.62M derived: sum of 2 quarters · filed 2026-03-06 | -$25.66M derived: sum of 3 quarters · filed 2026-03-06 | -$43.65M 10-K · filed 2026-03-06 |
| 2024-09-30 | -$8.52M 10-Q · filed 2025-11-07 | -$18.56M derived: sum of 2 quarters · filed 2025-11-07 | -$36.55M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | -$10.04M 10-Q · filed 2025-08-08 | -$28.03M 10-Q · filed 2025-08-08 | ||
| 2023-12-31 | -$66.00M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |